All lobbying filings

CHATTEM, INC D/B/A OPELLA

Lobbying for CHATTEM, INC D/B/A OPELLA · Healthcare related to nonprescription drugs and dietary supplements.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $200,000.00 expenses · posted Jul 16, 2026

Official filing document

Bills named in this filing 1

HR 1219
Oral Health Products Inclusion Act

Lobbying activity 3

Health Issues

Issues related to the regulatory pathway for dietary supplements; issues related to the regulatory pathway for non-prescription drugs; H.R.1219, Oral Health Products Inclusion Act.

Trade (domestic/foreign)

Tariffs

Consumer Issues/Safety/Products

Organized retail theft; stolen goods on online marketplaces.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.